Norepinephrine compositions and methods therefor
US11602508B2 · kind B2 · utility
1Cited by
22References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2022 |
| Grant date | Mar 14, 2023 |
| Priority date | — |
| Expiry date | Jul 25, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-norepinephrine and exhibit less than 5% degradation of total norepinephrine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.